Benzodiazepine Interaction With COVID-19 Drugs
Prim Care Companion CNS Disord
.
2021 Oct 28;23(6):21br03081.
doi: 10.4088/PCC.21br03081.
Authors
Kaushal Shah
1
2
3
,
Dhwani Kamrai
1
,
Sushma Srinivas
4
,
Nikhila Veluri
5
,
Gaurav Chaudhari
6
,
Chintan Trivedi
6
,
Zeeshan Mansuri
7
Affiliations
1
Griffin Memorial Hospital, Norman, Oklahoma.
2
Department of Psychiatry and Behavioral Sciences, Oklahoma State University, Tulsa, Oklahoma.
3
Corresponding author: Kaushal Shah, MD, MPH, 900 E Main St, Norman, OK 73071 (
[email protected]
).
4
A.J. Institute of Medical Sciences and Research Center, Mangalore, Karnataka, India.
5
Texas Tech University Health Sciences Center El Paso, El Paso, Texas.
6
Department of Psychiatry, Texas Tech University Health Science Center at Odessa/Permian Basin Odessa, Midland, Texas.
7
Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts.
PMID:
34710952
DOI:
10.4088/PCC.21br03081
No abstract available
MeSH terms
Benzodiazepines / adverse effects
COVID-19*
Humans
Pharmaceutical Preparations*
SARS-CoV-2
Substances
Pharmaceutical Preparations
Benzodiazepines